Objective: Primary closure after carotid endarterectomy (CEA) has been much maligned as an inferior technique with worse outcomes than in patch closure. Our purpose was to compare perioperative and long-term results of different CEA closure techniques in a large institutional experience. Methods: A consecutive cohort of CEAs between January 1, 2000, and December 31, 2010, was retrospectively analyzed. Closure technique was used to divide patients into three groups: primary longitudinal arteriotomy closure (PRC), patch closure (PAC), and eversion closure (EVC). End points were perioperative events, long-term strokes, and restenosis $70%. Multivariate regression models were used to assess the effect of baseline predictors. Results: There were 1737 CEA cases (bilateral, 143; mean age, 71.4 6 9.3 years; 56.2% men; 35.3% symptomatic) performed during the study period with a mean clinical follow-up of 49.8 6 36.4 months (range, 0-155 months). More men had primary closure, but other demographic and baseline symptoms were similar between groups. Half the patients had PAC, with the rest evenly distributed between PRC and EVC. The rate of nerve injury was 2.7%, the rate of reintervention for hematoma was 1.5%, and the length of hospital stay was 2.4 6 3.0 days, with no significant differences among groups. The combined stroke and death rate was 2.5% overall and 3.9% and 1.7% in the symptomatic and asymptomatic cohort, respectively. Stroke and death rates were similar between groups: PRC, 11 (2.7%); PAC, 19 (2.2%); EVC, 13 (2.9%). Multivariate analysis showed baseline symptomatic disease (odds ratio, 2.4; P [ .007) and heart failure (odds ratio, 3.1; P [ .003) as predictors of perioperative stroke and death, but not the type of closure. Cox regression analysis demonstrated, among other risk factors, no statin use (hazard ratio, 2.1; P [ .008) as a predictor of ipsilateral stroke and severe (glomerular filtration rate <30 mL/min/1.73 m 2 ) renal insufficiency (hazard ratio, 2.6; P [ .032) as the only predictor of restenosis $70%. Type of closure did not have any predictive value. Conclusions: In our study, baseline risk factors and statin use, but not the type of closure, affect perioperative and long-term outcomes after CEA. (J Vasc Surg 2016;64:678-83.) 
Carotid endarterectomy (CEA) remains an established strategy of stroke prevention in symptomatic and selected asymptomatic patients with carotid artery disease. [1] [2] [3] During the past 60 years, the surgical technique and perioperative care have evolved significantly, and in contemporary practice, the postoperative combined stroke and death rates have shifted to rates lower than 3%, as shown in large U.S. and European administrative databases with mixed symptomatic and asymptomatic patients. [4] [5] [6] [7] The anatomic durability has likewise improved, and restenosis rates have followed a similar trend, with the most recent clinical trials reporting rates as low as 3% to 7% ($70% restenosis) at 2 to 4 years. [8] [9] [10] [11] [12] The clinical course of recurrent stenosis is generally benign, and the accompanying neurologic events are roughly 1% to 5%. [11] [12] [13] [14] [15] [16] To date, there is a general consensus and guideline disfavoring the use of primary closure during CEA, as it may be associated with higher perioperative neurologic events and restenosis rates. 1, 2 Recent studies, including Carotid Revascularization Endarterectomy vs Stenting Trial (CREST) and National Surgical Quality Improvement Program (NSQIP) data, have challenged the perioperative outcome differences, whereas the clinical significance of restenosis at such low rates may be minimal. 6, 11, 17, 18 The existing uncertainty for the benefits of carotid patching is reflected by the fact that the preferences of individual surgeons vary widely, and it is estimated that globally, 60% to 80% of carotid surgeons use patch closure, whereas the majority of the remainder use primary closure over eversion. 4, 6, 12 The purpose of the study was to determine and to compare contemporary perioperative and long-term outcomes of CEA with respect to closure technique.
METHODS
The study protocol was approved and exempted from informed consent by the Institutional Review Board of the University of Pittsburgh Medical Center. Surgery of the University of Pittsburgh between January 1, 2000, and  December 31, 2010, were identified by the Current Procedural Terminology code 35301. Patient records were  reviewed for demographics, baseline risk factors, carotid duplex studies, indications, intraprocedural data, periprocedural complications, and long-term outcomes. Patients who underwent additional neck vascular procedures (eg, carotid to carotid bypass, carotid thrombectomy) or simultaneous coronary artery bypass were excluded from the study.
Study design. Consecutive individuals who underwent CEA at the Division of Vascular
Closure technique was used to divide patients into three groups: primary longitudinal arteriotomy closure (PRC), patch closure (PAC), and eversion closure (EVC).
The end points were perioperative events, long-term major cerebrovascular events, and restenosis $70%.
Definitions. All baseline risk factors were recorded on the basis of established diagnoses identified in the medical records (Current Procedural Terminology codes). Renal function/insufficiency was classified by the estimated glomerular filtration rate (GFR) at the time of surgery as normal (GFR $60 mL/min/1.73 m 2 ), moderate (GFR 30-59), and severe (GFR <30).
Carotid stenosis was defined as symptomatic if the patient had experienced neurologic ischemic events, such as transient ischemic attacks (lasting <24 hours), amaurosis fugax, or stroke, within 6 months before CEA.
The physician's experience was recorded on the basis of the annual volume within the studied cohort (<10 vs $10 CEAs per year).
Carotid duplex studies were performed by registered vascular technologists in a fully accredited vascular laboratory (by the Intersocietal Accreditation Commission) and reviewed by a vascular surgeon. The degree of internal carotid artery (ICA) stenosis (or restenosis) was primarily determined on the basis of ICA-common carotid artery (CCA) peak systolic velocity (PSV) ratios previously validated at our institution. At baseline and at each followup visit, ICA stenosis was categorized as follows: none or mild, <50% (ICA/CCA PSV, 0.1-1.9; PSV <125; enddiastolic velocity <140); moderate, 50% to 69% (ICA/ CCA PSV, 2.0-4.0); and severe, 70% to 99% (ICA/CCA PSV >4; PSV >230). Ipsilateral restenosis was recorded at two levels, $50% and $70%. Patients who did not have ultrasound follow-up studies for >2 years and showed ICA restenosis at a later year were censored at the date of last consecutive follow-up as the timing of disease recurrence would be inaccurate for the analysis.
Major cerebrovascular events included any ischemic stroke, ipsilateral or contralateral. These events were retrospectively recorded on the basis of existing diagnoses in the patients' follow-up medical records. Beyond 30 days, only the first ipsilateral and first contralateral stroke were captured in our database; thus, subsequent strokes have not been recorded and are not reported.
CEA. Our study represents the practice of 19 vascular surgeons ( Supplementary Table, online only). All cases were performed under general anesthesia and the majority under dual electroencephalographic and somatosensory evoked potentials monitoring. Operative technique and shunting practices were based on the physician's personal preference.
Follow-up. An initial postoperative carotid duplex ultrasound examination was performed 1 month after surgery and yearly thereafter, with some variations based on the physician's preference. More frequent studies were obtained in patients whose routine studies revealed evidence of early (<2 years) >50% restenosis or who had neurologic symptoms.
Statistical analysis. Descriptive characteristics are reported as mean 6 standard deviation or as number of cases and percentages. Differences among the three groups (PRC, PAC, EVC) were tested in pairs, using the twotailed c 2 or Fisher exact test for categorical predictors and the Student t-test for continuous predictors. Survival functions were estimated by the Kaplan-Meier method. Backward stepwise logistic regression and Cox regression models were used to assess the effect of baseline predictors at the perioperative and long-term outcomes, respectively. The models included all recorded risk factors, statins, indication for surgery, and physician's experience. All variables were dichotomous (yes-no) except for renal insufficiency, which was classified in three groups according to the GFR (GFR $60, GFR 30-59, GFR #30) and surgical technique (PRC, PAC, EVC). Results were considered statistically significant when P value was < .05. Data analysis was performed using Statistical Package for the Social Sciences, version 17 (SPSS Inc, Chicago, Ill).
RESULTS

Study population.
During the 11-year study period, 1594 patients underwent 1737 CEAs. In brief, 35.3% were symptomatic within 6 months before CEA, the mean age of the cohort was 71.4 6 9.3 years, and 56.2% were men. The distribution among groups was as follows: PRC, 412 (23.7%); PAC, 873 (50.3%); EVC, 452 (26.0%). A shunt was used in 15.8% of the PRC cases, in 70% of the PAC cases, and in 9.3% of the EVC cases; 69% of patients were discharged on a statin regimen. Table I summarizes baseline demographic and clinical characteristics of all groups. The PRC group had more men, fewer smokers, and fewer patients with COPD, hyperlipidemia, and hypertension as well as more experienced surgeons compared with the PAC group. The rest of the demographics and baseline symptoms were similar between groups.
Perioperative outcomes. Operating room stay time (in and out) was significantly lower for the PRC group (93 6 25 minutes) vs both PAC (129 6 41 minutes; P < .0001) and EVC (107 6 37 minutes; P < .0001). The rate of nerve injury was 2.7%, the rate of reintervention for hematoma was 1.5%, and the length of hospital stay was 2.4 6 3.0 days, with no significant differences among groups.
Periprocedural stroke and death rates were 1.8% and 0.7%, respectively. The combined stroke and death rate was 2.5% overall and 3.9% and 1.7% in the symptomatic and asymptomatic cohort, respectively. Stroke and death rates were similar between groups: PRC, 11 (2.7%); PAC, 19 (2.2%); EVC, 13 (2.9%). All perioperative outcomes are summarized in Table II .
Multivariate analysis showed baseline symptomatic disease (odds ratio, 2.4; P ¼ .007) and heart failure (odds ratio, 3.1; P ¼ .003) to be predictors of perioperative stroke and death, but not the type of closure or the surgeon's experience, which were removed as nonsignificant during the backward stepwise analysis.
Long-term outcomes. The mean clinical follow-up for the entire cohort was 49.8 6 36.4 months (range, 0-155 months). A total of 1313 cases had retrievable records of follow-up imaging.
During the follow-up, 146 (11.1%) patients developed a $50% restenosis, and 58 (3.3%) patients progressed to $70% restenosis. The rate of restenosis at 2, 5, and 10 years was 8.4%, 15.7%, and 27.6% for restenosis $50% and 3.4%, 6.5%, and 10.3% for restenosis $70%, respectively. Stratification of patients by closure technique demonstrated EVC to have the highest restenosis rates at the 50% level; but at the 70% level, there was no difference between groups at 5 and 10 years (Table III) Ipsilateral and any stroke rates were 8.4% and 16% at 10 years, respectively, for the entire cohort (rates include the perioperative strokes). Excluding the perioperative strokes, follow-up ipsilateral and any stroke rates were 6.3% and 14.8%. In either analysis, there was no difference between groups (Table III) .
Cox regression analysis demonstrated, among other risk factors, no statin use (hazard ratio [HR], 2.1; P ¼ .008) as a predictor of ipsilateral stroke and severe renal insufficiency (HR, 2.6; P ¼ .032) as the only predictor of restenosis $70%. Type of closure did not have any predictive value for either stroke or restenosis (Table IV) .
DISCUSSION
Primary closure after CEA has been much maligned as an inferior technique to patch closure, despite emerging evidence challenging this dogma. Our study results indicated that baseline risk factors and statin use but not the type of closure affect perioperative and long-term outcomes after CEA. Primary closure can be performed with equivalent results to other techniques. Various systematic reviews and meta-analyses have studied the effect of the type of closure in CEA outcomes. [19] [20] [21] The first Cochrane review published in 2004 showed a clear benefit for patch over primary closure in perioperative stroke and death, long-term ipsilateral stroke, and restenosis. 19 An updated Cochrane review published in 2009 showed no difference in perioperative events, although patch closure was still beneficial in the longer term in terms of stroke and restenosis. 20 Based on these, both U.S. and European guidelines currently recommend patch over primary closure. 1, 2 More recently, Rerkasem and Rothwell updated these systematic reviews, adding three more randomized controlled trials. 21 Whereas the overall results did not change, the authors highlighted the fact that the two most recent trials both reported nonsignificant trends toward an increased operative risk of stroke and death with patch closure and concluded that more data are needed. 17, 21, 22 In line with this reversing trend are the 2012 NSQIP data and the CREST subanalysis. 6, 12, 21 The NSQIP data analysis of 3845 patients showed that the variables independently associated with postoperative stroke and death (4.4% for PRC vs 4.7% for PAC; P ¼ .82) after risk adjustment were age >80 years, active smoking, contralateral ICA stenosis of 80% to 99%, emergency procedure, preoperative stroke, presence of one or more NSQIP-defined high-risk characteristics (class III/IV congestive heart failure, left ventricular ejection fraction <30%, recent unstable angina, or recent myocardial infarction), and operative time >150 minutes, but not the technical features of CEA. The recent CREST secondary analysis of 1151 patients, although demonstrating significant reduction of 2-year restenosis rates with the use of patch (HR, 0.35; P ¼ .006), did not show any differences in adjusted periprocedural stroke and death (HR, 1.58; P ¼ .57) or 4-year ipsilateral stroke rates (HR, 1.23; P ¼ .71). These results are in agreement with our findings. Interestingly, whereas we did not identify any differences between PRC and PAC, eversion CEA seemed to have an inferior restenosis rate compared with both groups, but still without differences in clinical outcomes.
Contemporary perioperative care and medical treatment seem to detract the clinical significance of CEA technique in short-term and longer term outcomes. Prior evidence favoring patching was based on dated studies at a time that best medical treatment, including perioperative use of aspirin and statins, was not prevalent. 19, 20 The aforementioned reversing trend in recent literature mirrors the overall changing medical practice and improved overall clinical outcomes. [23] [24] [25] [26] Although it seems to be accepted now that the risk of stroke after CEA is declining and that it is not associated with the closure technique, regarding restenosis rates, the jury may still be out, despite our opposing results. 12, 21, 22 Contemporary randomized [8] [9] [10] [11] [12] Of these, the symptomatic ones are 1% to 5%, [8] [9] [10] [11] [12] that is, <0.35% when accounting for the overall CEA population, a rate that is of questionable clinical significance, particularly considering that not all strokes are related to carotid disease. Technical considerations on the technique of primary closure include the short arteriotomy, ideally confined within the bulb, and fine bites in proximity to one another. The technique has been reported in recent literature with excellent outcomes. 18, 27 Interestingly, a very recent study on the hemodynamics of CEA closure techniques found no favorable flow dynamics after patching because incorporation of a patch increases areas of low wall shear stress and high oscillatory shear index at the bifurcation. 28 Primary closure otherwise has the advantage of eliminating graftspecific complications and reducing cross-clamp times in comparison with patch angioplasty. Neurocognitive decline, an outcome not taken into consideration in trials comparing patch angioplasty with primary closure, may be associated with longer clamping times; thus, the shorter clamping times afforded with the single suture line of primary closure seem more appealing. 29, 30 The results of our study need to be interpreted with caution, given its retrospective nature and a possible selection bias. Potential selective patching for very small ICAs could not be recorded reliably; however, the surgeons among the authors who preferably do primary closure have rarely used a patch. Postoperative and long-term events were determined from record reviews and chart diagnoses. It is possible that patients with limited follow-up developed neurologic events and were treated elsewhere so that symptomatic patients would be underrepresented in our analysis. Transient ischemic attacks during the follow-up were not accurately captured unless the patients had a procedure on their account; our analysis accounted for strokes only, so the actual symptomatic conversion of restenosis may have been underestimated. Nonetheless, we present an appropriately matched large cohort of patients treated with CEA and are able to conclude that the type of closure technique does not have an impact on perioperative and long-term outcomes in current practice.
CONCLUSIONS
In our contemporary practice, baseline risk factors and statin use but not the type of closure affect perioperative and long-term outcomes after CEA. Primary closure can be performed with equivalent results to other techniques.
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